Skip to main content
Year archive

ADALTA LIMITED — 2019 filings

All 71 regulatory filings released by ADALTA LIMITED (1AD) in 2019, sourced directly from the official regulator.

71 Filings
2019 Period
2019 filings (71)
Filing Released Lang
R&D Tax Incentive Facility 2 pages 847.6KB
Capital/Financing Update
2019-12-19 English
AdAlta awarded Biomedical Translation Bridge Funding 3 pages 860.3KB
Capital/Financing Update
2019-12-11 English
Appendix 3B 15 pages 1.3MB
Capital/Financing Update
2019-12-11 English
Appendix 3B 13 pages 556.0KB
Share Issue/Capital Change
2019-11-28 English
Change of Director's Interest Notice - TO 2 pages 266.2KB
Director's Dealing
2019-11-28 English
AGM Script 14 pages 920.3KB
AGM Information
2019-11-25 English
AGM Presentation 22 pages 1.4MB
AGM Information
2019-11-25 English
Results of Meeting 1 page 9.2KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-25 English
Appendix 3B 13 pages 565.1KB
Capital/Financing Update
2019-11-13 English
Appendix 4C - quarterly 7 pages 301.1KB
Interim / Quarterly Report
2019-10-30 English
AusBiotech Conference Presentation 25 pages 2.9MB
Regulatory Filings
2019-10-29 English
GLP Toxicology study results 3 pages 110.9KB
Capital/Financing Update
2019-10-28 English
Notice of Annual General Meeting/Proxy Form 55 pages 763.0KB
AGM Information
2019-10-23 English
Investor Presentation for Australian Microcap Conference 24 pages 1.6MB
Investor Presentation
2019-10-21 English
Tim Oldham Appointed as Chief Executive Officer 4 pages 124.2KB
Board/Management Information
2019-10-08 English
Initial Director's Interest Notice 2 pages 67.7KB
Director's Dealing
2019-10-08 English
GE Healthcare licensing deal 2 pages 102.6KB
Capital/Financing Update
2019-09-25 English
Receipt of R&D Tax Incentive 2 pages 71.8KB
Capital/Financing Update
2019-09-17 English
Ceasing to be a substantial holder 3 pages 111.1KB
Major Shareholding Notification
2019-09-17 English
AdAlta secures licensing deal with GE Healthcare 2 pages 136.2KB
Regulatory Filings
2019-09-15 English
mAbs publication on customisation of the i-body half-life 13 pages 4.2MB
Regulatory Filings
2019-09-03 English
Preliminary Final Report 2 pages 513.5KB
Regulatory Filings
2019-08-28 English
Annual Report to shareholders 56 pages 1.1MB
Annual Report
2019-08-28 English
Appendix 4G and Corporate Governance Statement 21 pages 428.8KB
Regulatory Filings
2019-08-28 English
Final Director's Interest Notice 2 pages 233.6KB
Director's Dealing
2019-08-25 English
Ceasing to be a substantial holder 2 pages 116.7KB
Regulatory Filings
2019-08-20 English
Executive team changes 2 pages 101.4KB
Board/Management Information
2019-08-11 English
Director Appointment - Ros Wilson 2 pages 111.8KB
Board/Management Information
2019-07-31 English
Initial Director's Interest Notice 2 pages 70.9KB
Director's Dealing
2019-07-31 English
Appendix 4C - quarterly 6 pages 240.0KB
Interim / Quarterly Report
2019-07-30 English
Ceasing to be a substantial holder 2 pages 107.9KB
Major Shareholding Notification
2019-07-28 English
AdAlta to present at 2019 Bioshares Biotech Summit 26 pages 11.7MB
Investor Presentation
2019-07-25 English
GLP toxicology study commences 2 pages 103.2KB
Regulatory Filings
2019-07-15 English
Change in substantial holding 2 pages 161.0KB
Major Shareholding Notification
2019-07-04 English
Becoming a substantial holder 3 pages 221.7KB
Major Shareholding Notification
2019-07-04 English
Change in substantial holding 4 pages 210.8KB
Director's Dealing
2019-07-03 English
Appendix 3B & Cleansing Notice 13 pages 225.3KB
Capital/Financing Update
2019-07-02 English
Change in Director Interest Notice x 4 11 pages 168.4KB
Director's Dealing
2019-07-02 English
Results of Extraordinary General Meeting 27 June 2019 1
Declaration of Voting Results & Voting Rights Announcements
2019-06-26 English
Becoming a substantial holder 2 pages 104.0KB
Regulatory Filings
2019-06-23 English
Appendix 3B 12 pages 135.9KB
Capital/Financing Update
2019-06-17 English
Appendix 3B 15 pages 262.0KB
Capital/Financing Update
2019-06-16 English
Appendix 3B - Revised 15 pages 261.9KB
Capital/Financing Update
2019-06-16 English
Entitlement Offer Results and Shortfall Notification 3 pages 111.6KB
Capital/Financing Update
2019-06-13 English
Appendix 3B 11 pages 142.0KB
Capital/Financing Update
2019-06-04 English
Dispatch of Entitlement Offer documents 60 pages 759.2KB
Capital/Financing Update
2019-05-30 English
Change in substantial holding 2 pages 110.2KB
Major Shareholding Notification
2019-05-30 English
Cleansing Notice 1 page 134.7KB
Capital/Financing Update
2019-05-28 English
Appendix 3B 12 pages 144.2KB
Capital/Financing Update
2019-05-28 English
Notice of Extraordinary General Meeting/Proxy Form 18 pages 498.0KB
Proxy Solicitation & Information Statement
2019-05-27 English
Letter to Eligible Shareholders 3 pages 780.8KB
Capital/Financing Update
2019-05-23 English
Letter to Ineligible shareholders 3 pages 769.8KB
Capital/Financing Update
2019-05-23 English
Completion of Capital Raise - $5 million 5 pages 133.4KB
Capital/Financing Update
2019-05-22 English
Investor Presentation 24 pages 3.0MB
Investor Presentation
2019-05-22 English
Prospectus 55 pages 423.3KB
Capital/Financing Update
2019-05-22 English
Appendix 3B - Entitlement Offer 13 pages 140.1KB
Capital/Financing Update
2019-05-22 English
AdAlta CEO discusses capital raise 1 page 98.0KB
Capital/Financing Update
2019-05-22 English
Letter to Optionholders 3 pages 767.3KB
Capital/Financing Update
2019-05-22 English
Trading Halt 2 pages 344.1KB
Capital/Financing Update
2019-05-20 English
Response to financial media publication 1 page 94.6
Director's Dealing
2019-05-05 English
AD-214 manufacturing update 2 pages 103.5KB
Regulatory Filings
2019-05-01 English
Appendix 3B 15 pages 227.0KB
Capital/Financing Update
2019-04-28 English
Change of Director's Interest Notice (Sam Cobb) 4 pages 57.5KB
Director's Dealing
2019-04-28 English
Appendix 4C - quarterly 6 pages 293.8KB
Interim / Quarterly Report
2019-04-28 English
Major shareholder fund expiry extended 2 pages 751.3KB
Capital/Financing Update
2019-03-11 English
Collaboration with Excellerate Bioscience 3 pages 757.7KB
Regulatory Filings
2019-02-27 English
Half Yearly Report and Accounts 22 pages 844.8KB
Interim / Quarterly Report
2019-02-27 English
Investor and analyst briefing presentation 123 pages 7.4MB
Investor Presentation
2019-01-30 English
Manufacturing update 23 pages 7.6MB
Capital/Financing Update
2019-01-28 English
Appendix 4C - quarterly 6 pages 872.7KB
Interim / Quarterly Report
2019-01-21 English
Appendix 3B 12 pages 141.3KB
Capital/Financing Update
2019-01-20 English